Evofem Reports Fourth Consecutive Year of Net Sales Growth
Provided By PR Newswire
Last update: Mar 24, 2025
-- 2024 Net Sales Increased 6% to $19.4 Million --
-- Total Operating Expense Reduced 27% from 2023 Levels,
Excluding Non-cash Amortization Expense --
-- Sales and Marketing Expense as a Percentage of Net Sales was 47% for 2024 and
31% for the Fourth Quarter, the Most Favorable Ratios since the PHEXXI Launch --
1.2
-0.02 (-1.64%)
Find more stocks in the Stock Screener
ADTX Latest News and Analysis
10 days ago - ChartmillUnusual volume stocks in Wednesday's sessionThe trading volume of these stocks is deviating from the norm in today's session.
16 days ago - ChartmillWhich stocks have an unusual volume on Thursday?Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
17 days ago - ChartmillLet's have a look at the top gainers and losers one hour before the close of the markets of today's session.Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
